hypogonadism; aromatase inhibitors; hpga/fertility

* The response to AIs is variable, and their long-term safety in men remains uncertain. In addition, the use of AIs is off-label and lacks robust clinical evidence. Well-designed trials are needed to determine whether AIs are truly a viable harm reduction strategy and eventually reduce the...